Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALXN1007 in Healthy Male and Female Subjects
A Phase 1, Randomized, Blinded, Placebo-Controlled, Multiple IV Administration, Sequential-Cohort, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALXN1007 in Healthy Male and Female Subjects
Study Complete
Study Details
Medical Condition
Study Phase
Intervention Type
Product
DateMedical ConditionRequirement Information
Date
AgeDateParticipation Requirements
Inclusion Criteria
Exclusion CriteriaInclusion CriteriaThe purpose of the study is to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of multiple intravenous (IV) doses of ALXN1007 in healthy male and female subjects.
| Location | Status |
|---|---|
Location United States, Maryland PAREXEL Baltimore EPCU Baltimore, Maryland, United States, 21225 | Status Not Available |
